Non-contraceptive benefits of contraceptives
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Our patients remain convinced that the birth control pill increases cancer risk. Yet one of the pill’s unappreciated benefits is the remarkable protection it can afford against ovarian cancer. This is but one of the non-contraceptive benefits of contraceptives that we will explore. You are listening to ReachMD, at our new home on XM 157. We are the Channel for medical professionals. In this show, we will be discussing Non-contraceptive benefits of birth control options. Dr. Robert Hatcher joins us to discuss benefits of contraception beyond mere birth control. He is a professor of Gynecology and Obstetrics at the Emory University School of Medicine. Many in our audience will recognize him as the lead author of Contraceptive Technology, perhaps the most comprehensive book on contraception available. First written by Dr. Hatcher in 1967, the book’s 19th edition will be available shortly.
Overview
Our patients remain convinced that the birth control pill increases cancer risk. Yet one of the pill’s unappreciated benefits is the remarkable protection it can afford against ovarian cancer. This is but one of the non-contraceptive benefits of contraceptives that we will explore. You are listening to ReachMD, at our new home on XM 157. We are the Channel for medical professionals. In this show, we will be discussing Non-contraceptive benefits of birth control options. Dr. Robert Hatcher joins us to discuss benefits of contraception beyond mere birth control. He is a professor of Gynecology and Obstetrics at the Emory University School of Medicine. Many in our audience will recognize him as the lead author of Contraceptive Technology, perhaps the most comprehensive book on contraception available. First written by Dr. Hatcher in 1967, the book’s 19th edition will be available shortly.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Level Up Your Skills: Tailoring Management of HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?